(CRS) Carpenter Technology - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1442851036

Specialty Alloys, Titanium, Stainless Steel, Tool Steel, Metal Powders

Dividends

Dividend Yield 0.26%
Yield on Cost 5y 2.99%
Yield CAGR 5y 0.00%
Payout Consistency 89.7%
Payout Ratio 9.8%
Risk via 10d forecast
Volatility 42.2%
Value at Risk 5%th 64.6%
Relative Tail Risk -6.94%
Reward TTM
Sharpe Ratio 1.08
Alpha 39.84
CAGR/Max DD 3.53
Character TTM
Hurst Exponent 0.477
Beta 1.488
Beta Downside 1.643
Drawdowns 3y
Max DD 28.74%
Mean DD 6.43%
Median DD 4.58%

Description: CRS Carpenter Technology October 31, 2025

Carpenter Technology Corp. (NYSE: CRS) manufactures and distributes specialty metals-including titanium alloys, powder metals, stainless, alloy, and tool steels-through its Specialty Alloys Operations and Performance Engineered Products segments, serving aerospace, defense, medical, transportation, energy, industrial and consumer markets worldwide.

In FY 2023 the company generated roughly $1.9 billion in revenue with an operating margin near 9%, while its exposure to aerospace and defense ties earnings to U.S. defense spending trends and the cyclical recovery of commercial jet production. Recent steel and titanium price volatility, driven by supply-chain bottlenecks and shifting ESG regulations, remains a material risk to margins; conversely, rising demand for lightweight, high-strength alloys in electric-vehicle and renewable-energy applications offers a secular growth tailwind.

For a deeper quantitative assessment, you may find ValueRay’s detailed financial models and scenario analysis useful.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (413.7m TTM) > 0 and > 6% of Revenue (6% = 173.6m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 1.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 44.77% (prev 40.85%; Δ 3.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.13 (>3.0%) and CFO 439.4m > Net Income 413.7m (YES >=105%, WARN >=100%)
Net Debt (496.2m) to EBITDA (711.6m) ratio: 0.70 <= 3.0 (WARN <= 3.5)
Current Ratio 4.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (50.4m) change vs 12m ago -0.59% (target <= -2.0% for YES)
Gross Margin 27.95% (prev 22.53%; Δ 5.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 86.92% (prev 86.80%; Δ 0.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 9.63 (EBITDA TTM 711.6m / Interest Expense TTM 59.2m) >= 6 (WARN >= 3)

Altman Z'' 6.83

(A) 0.38 = (Total Current Assets 1.67b - Total Current Liabilities 376.9m) / Total Assets 3.40b
(B) 0.54 = Retained Earnings (Balance) 1.82b / Total Assets 3.40b
(C) 0.17 = EBIT TTM 570.2m / Avg Total Assets 3.33b
(D) 1.37 = Book Value of Equity 2.04b / Total Liabilities 1.49b
Total Rating: 6.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 83.16

1. Piotroski 7.50pt
2. FCF Yield 1.66%
3. FCF Margin 9.31%
4. Debt/Equity 0.37
5. Debt/Ebitda 0.70
6. ROIC - WACC (= 8.08)%
7. RoE 22.68%
8. Rev. Trend 80.84%
9. EPS Trend 97.66%

What is the price of CRS shares?

As of December 08, 2025, the stock is trading at USD 307.12 with a total of 978,588 shares traded.
Over the past week, the price has changed by -2.98%, over one month by -6.37%, over three months by +22.03% and over the past year by +67.38%.

Is CRS a buy, sell or hold?

Carpenter Technology has received a consensus analysts rating of 4.29. Therefore, it is recommended to buy CRS.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CRS price?

Issuer Target Up/Down from current
Wallstreet Target Price 382.4 24.5%
Analysts Target Price 382.4 24.5%
ValueRay Target Price 455.5 48.3%

CRS Fundamental Data Overview December 03, 2025

Market Cap USD = 15.78b (15.78b USD * 1.0 USD.USD)
P/E Trailing = 38.6508
P/E Forward = 16.5563
P/S = 5.4542
P/B = 8.3033
P/EG = 1.5913
Beta = 1.307
Revenue TTM = 2.89b USD
EBIT TTM = 570.2m USD
EBITDA TTM = 711.6m USD
Long Term Debt = 695.7m USD (from longTermDebt, last quarter)
Short Term Debt = 8.50m USD (from shortTermDebt, last quarter)
Debt = 704.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 496.2m USD (from netDebt column, last quarter)
Enterprise Value = 16.28b USD (15.78b + Debt 704.2m - CCE 208.0m)
Interest Coverage Ratio = 9.63 (Ebit TTM 570.2m / Interest Expense TTM 59.2m)
FCF Yield = 1.66% (FCF TTM 269.4m / Enterprise Value 16.28b)
FCF Margin = 9.31% (FCF TTM 269.4m / Revenue TTM 2.89b)
Net Margin = 14.30% (Net Income TTM 413.7m / Revenue TTM 2.89b)
Gross Margin = 27.95% ((Revenue TTM 2.89b - Cost of Revenue TTM 2.08b) / Revenue TTM)
Gross Margin QoQ = 29.49% (prev 28.32%)
Tobins Q-Ratio = 4.78 (Enterprise Value 16.28b / Total Assets 3.40b)
Interest Expense / Debt = 1.63% (Interest Expense 11.5m / Debt 704.2m)
Taxrate = 15.40% (22.3m / 144.8m)
NOPAT = 482.4m (EBIT 570.2m * (1 - 15.40%))
Current Ratio = 4.44 (Total Current Assets 1.67b / Total Current Liabilities 376.9m)
Debt / Equity = 0.37 (Debt 704.2m / totalStockholderEquity, last quarter 1.91b)
Debt / EBITDA = 0.70 (Net Debt 496.2m / EBITDA 711.6m)
Debt / FCF = 1.84 (Net Debt 496.2m / FCF TTM 269.4m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.16% (Net Income 413.7m / Total Assets 3.40b)
RoE = 22.68% (Net Income TTM 413.7m / Total Stockholder Equity 1.82b)
RoCE = 22.63% (EBIT 570.2m / Capital Employed (Equity 1.82b + L.T.Debt 695.7m))
RoIC = 19.15% (NOPAT 482.4m / Invested Capital 2.52b)
WACC = 11.07% (E(15.78b)/V(16.48b) * Re(11.50%) + D(704.2m)/V(16.48b) * Rd(1.63%) * (1-Tc(0.15)))
Discount Rate = 11.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 67.60% ; FCFE base≈244.1m ; Y1≈255.9m ; Y5≈298.2m
Fair Price DCF = 62.26 (DCF Value 3.10b / Shares Outstanding 49.8m; 5y FCF grow 5.18% → 3.0% )
EPS Correlation: 97.66 | EPS CAGR: 159.6% | SUE: 2.72 | # QB: 3
Revenue Correlation: 80.84 | Revenue CAGR: 17.87% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.56 | Chg30d=+0.003 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-06-30): EPS=10.12 | Chg30d=+0.375 | Revisions Net=+2 | Growth EPS=+35.3% | Growth Revenue=+7.2%
EPS next Year (2027-06-30): EPS=11.33 | Chg30d=+0.232 | Revisions Net=+1 | Growth EPS=+11.9% | Growth Revenue=+9.9%

Additional Sources for CRS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle